Driehaus Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-217,752
| Closed | -$11.6M | – | 395 |
|
|
2022
Q3 | $11.6M | Sell |
217,752
-36,995
| -15% | -$1.97M | 0.18% | 173 |
|
|
2022
Q2 | $14.9M | Sell |
254,747
-86,453
| -25% | -$5.04M | 0.24% | 143 |
|
|
2022
Q1 | $26M | Buy |
+341,200
| New | +$26M | 0.32% | 105 |
|
|
2020
Q4 | – | Sell |
-121,069
| Closed | -$7.28M | – | 449 |
|
|
2020
Q3 | $7.28M | Buy |
+121,069
| New | +$7.28M | 0.15% | 172 |
|
|
2016
Q1 | – | Sell |
-47,599
| Closed | -$3.66M | – | 596 |
|
|
2015
Q4 | $3.66M | Buy |
47,599
+34,755
| +271% | +$2.67M | 0.12% | 186 |
|
|
2015
Q3 | $528K | Sell |
12,844
-688
| -5% | -$28.3K | 0.02% | 408 |
|
|
2015
Q2 | $957K | Sell |
13,532
-40,902
| -75% | -$2.89M | 0.03% | 409 |
|
|
2015
Q1 | $4.84M | Sell |
54,434
-36,764
| -40% | -$3.27M | 0.17% | 149 |
|
|
2014
Q4 | $8.09M | Buy |
91,198
+25,189
| +38% | +$2.23M | 0.33% | 72 |
|
|
2014
Q3 | $6.4M | Buy |
66,009
+32,575
| +97% | +$3.16M | 0.24% | 108 |
|
|
2014
Q2 | $3.07M | Buy |
+33,434
| New | +$3.07M | 0.1% | 272 |
|
|
2013
Q4 | – | Sell |
-35,780
| Closed | -$1.72M | – | 504 |
|
|
2013
Q3 | $1.72M | Buy |
35,780
+6,983
| +24% | +$336K | 0.07% | 290 |
|
|
2013
Q2 | $835K | Buy |
+28,797
| New | +$835K | 0.04% | 351 |
|